Mr. Wehrly is the group president of Covidien, and has more than 25 years experience in the medical device field. He formerly served as president of Medtronic’s $3 billion spinal, biologics and navigation division.
More Articles on Devices:
Bionic Device Market to Grow 7.1% in 5 Years
OrthoSensor Develops Knee Device to Improve Implant Placement
Stryker Invests $30M in Overseas Device Research and Development
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.